Functional mitral regurgitation. Physiopathology and impact of medical therapy and left ventricular surgical reduction techniques;Insuficiencia mitral funcional. Fisiopatologia e impacto del tratamiento medico y de las tecnicas quirurgicas de reduccion ventricular izquierda

Revista Espanola de Cardiologia

Volumn 52, Issue 7, 1999, Pages 512-520

  Comín, Josep ^b   Manito, Nicolás ^b   Roca, Josep ^b   Castells, Eduard ^b   Esplugas, Enric ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

Batista's procedure; Heart failure; Mitral regurgitation; Partial left ventriculectomy; Remodelling

Indexed keywords

INOTROPIC AGENT; VASODILATOR AGENT;

HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART SURGERY; HUMAN; ISCHEMIC HEART DISEASE; MITRAL VALVE REGURGITATION; PATHOPHYSIOLOGY; REVIEW; SURGICAL TECHNIQUE; SURVIVAL; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE;

CARDIAC SURGICAL PROCEDURES; HEART VENTRICLES; HUMANS; MITRAL VALVE INSUFFICIENCY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033162756     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(99)74959-6     Document Type: Review

References (62)

1. Perloff JK, Roberts WC. The mitral apparatus. Functional anatomy of mitral regurgitation. Circulation 1972; 46: 227-238.
2. Adler DS, Goldman L, O'Neil A. Cook EF, Mudge GH Jr, Shemin RJ et al. Long term survival of more than 2,000 patients after coronary artery bypass grafting. Am J Cardiol 1986; 58: 195-202.
3. Lehman KG, Francis CK, Dodge HT and the TIMI Study Group. Mitral regurgitation in early myocardial infarction: incidence, clinical detection and prognostic implications. Ann Intern Med 1992; 117: 10-17.
4. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Gersch BJ, Basta L et al. Significación clínica de la regurgitación mitral después de un infarto agudo de miocardio. Circulation 1997; 96: 827-833.
5. Blondheim S, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of ventricular thrombus. Am Heart J 1991; 122: 763-771.
6. Burch GE, De Pasquale NP, Philips JH. The syndrome of papillary muscle dysfunction. Am Heart J 1968; 75: 399-415.
7. Sabbah HN, Rosman H, Kono T, Alam M, Khaja F, Goldstein S. On the mechanism of functional mitral regurgitation. Am J Cardiol 1993; 72: 1.074-1.076.
8. Sabbah HN, Kono T, Rosman H, Jafry S, Stein P, Goldstein S. Left ventricular shape: a factor in the etiology of fuctional mitral regurgitation in heart failure. Am Heart J 1992; 123: 961-966.
9. Kono T, Sabbah HN, Stein PD, Brymer JF, Khaja F. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1991; 68: 355-359.
10. Mittal AK, Langston M, Cohn KE, Selzer A, Kertz WJ. Combined papillary muscle and left ventricular wall dysfunction as a cause of mitral regurgitation. Circulation 1971; 44: 174-180.
11. Tsakiris AG, Rastelli GC, Amorin D, Titus JL, Wood E. Effect of experimental papillary muscle damage on mitral valve closure in intact anesthetized dogs. Mayo Clin Proc 1970; 45: 275-285.
12. Godley RW, Wann LS, Rogers EW, Feigenbaum H, Weyman AE. Incomplete mitral leaflet closure in patients with papillary muscle dysfunction. Circulation 1981; 63: 565-571.
13. Llaneras MR, Nance ML, Streicher JT, Linden PL, Downing SW, Lima JAC et al. Pathogenesis of ischemic mitral insufficiency. J Thorac Cardiovasc Surg 1993; 105: 439-443.
14. Kono T, Sabbah HN, Rosman H, Alam M, Jafris S, Stein PD et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992; 20: 1.594-1.598.
15. Sabbah HN, Kono T, Stein PD, Mancini GBJ, Goldstein S. Left ventricular shape changes during the course of evolving heart failure. Am J Physiol 1992; 263: H266-H270.
16. Lamas GA, Vaughan DE, Parisi AF, Pfeffer MA. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol 1989; 63: 1.167-1.173.
17. Douglas PS, Morow R. Ioli A, Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989; 13: 311-315.
18. Boltwood CM, Tei C, Wong M, Shah PM. Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation. Circulation 1983; 68: 488-508.
19. Chandraratna PAN, Aronow WS. Mitral valve ring in normal vs dilated left ventricle. Cros-sectional echocardiographic study. Chest 1981; 79: 151-154.
20. Brock RC. The surgical and pathologic anatomy of the mitral valve. Br Heart J 1952; 14: 489-513.
21. He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated mechanism for functional mitral regurgitation. Leaflet restriction versus coapting force: in vitro studies. Circulation 1997; 96: 1.826-1.834.
22. Nass O, Rosman H, Al-Khaled N, Shimoyama H, Alam M, Sabbah HN et al. Relation of left ventricular chamber shape in patients with low (< 40%) ejection fraction to severity of functional mitral regurgitation. Am J Cardiol 1995; 76: 402-404.
23. Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L, Song J-K, Guerrero JL et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation. Direct in vivo demonstration of altered leaflet tethering geometry. Circulation 1997; 96: 1.999-2.008.
24. Gilon D, Lee M-Y, Jiang L, Otsuji Y, Karvounis H, Roy MJ et al. Absence of functional mitral regurgitation despite severely reduced left ventricular function: insights into the mechanism of MR [resumen]. J Am Coll Cardiol 1996; 27: 115 A.
25. Yoran C, Yellin EL, Becker RM, Gabbay S, Frater RWM, Sonnenblick EH. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Circulation 1979; 60: 170-176.
26. Schwammenthal E, He S, Weyman AE, Yoganathan AP, Levine RA, Fontaine AA. The impact of driving pressure on effective regurgitant orifice area in incomplete mitral valve closure [resumen]. J Am Coll Cardiol 1994; 23: 176 A.
27. Fontaine AA, He S, Ellis JT, Schwammenthal E, Levine RA, Yoganathan AP. Dynamic orifice area variation in functional mitral regurgitation: in vitro reproduction and mechanistic insights [resumen]. J Am Coll Cardiol 1996; 27: 37 A.
28. Jiang L, Lee M-Y, Otsuji Y, Gilon D, Handschumacher MD, Guerrero L et al. Insights into mechanism of incomplete mitral leaflet closure from an in vivo study [resumen]. J Am Coll Cardiol 1996; 27: 238 A.
29. Levine HJ, Gaasch WH. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996; 28: 1.083-1.091.
30. Greenberg BH, Massie BM, Brundage BH, Botvinick EH, Parmley WW, Chatterjee K. Beneficial effects of hydralazine in severe mitral regurgitation. Circulation 1978; 58: 273-279.
31. Greenberg BH, DeMots H, Murphy E, Rahimtoola SH. Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up. Circulation 1982; 65: 181-187.
32. Keren G, Katz S, Strom J, Sonnenblick EH, Ledemtel TH. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 1989; 80: 306-313.
33. Roth A, Shotan A, Elkayam V. A randomized comparison between the hemodynamic effects of hydralazine and nitroglycerin alone and in combination at rest and during isometric exercise in patients with chronic mitral regurgitation. Am Heart J 1993; 125: 155.
34. Klein AL, Savage RM, Kahan F, Murray RD, Thomas JD, Steward WJ et al. Experimental and numerically modeled effects of altered loading conditions on pulmonary venous flow and left atrial pressure in patients with mitral regurgitation. J Am Soc Echocardiogr 1997; 10: 41-51.
35. Jeang MK, Petrovich LJ, Adyanthaya AV, Alexander JK. Effects of isosorbide dinitrate on rheumatic and non-reumathic mitral regurgitation. Texas Heart Inst J 1986; 13: 453-457.
36. Heck I, Schmidt J, Mattern H, Fricke G, Kropp J, Reske S. Reduktion der regurgitation bie aorten-und mitralinsuffizienz durch captopril im akut-und langzeit versuch. Scweiz Med Wochenschr 1985; 115: 1.615-1.618.
37. Schön HR, Schröter G, Barthel P, Schömig A. Quinapril therapy in patients with chronic mitral regurgitation. J Heart Valve Dis 1994; 3: 303-332.
38. Seneviratne B, Moore GA, West PD. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controled trial. Br Heart J 1994; 72: 63-68.
39. Wisenbaugh T, Essop R, Rothlisberger C, Sareli P. Effects of a single dose of captopril on left ventricular performance in severe mitral regurgitation. Am J Cardiol 1992; 69: 348-353.
40. Wisenbaugh T, Sinovich V, Dullabh A, Sarelli P. Six month pilot study of captopril for midly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994; 3: 197-204.
41. Cooper HA, Gersh BJ. Treatment of chronic mitral regurgitation. Am Heart J 1998; 135: 925-936.
42. Evangelista-Masip A, Bruguera-Cortada J, Serrat-Serradell R, Robles-Castro A, Galve-Basilio E, Alijarde-Guimera et al. Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 69: 373-376.
43. Chatterjee K, Parmley WW, Swan HJC, Berman G, Forrester J, Marcus HS. Beneficial effects of vasodilators agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus. Circulation 1973; 48: 684-690.
44. Sasayama S, Ohyagi A, Lee JD. Effect of the vasodilator therapy in regurgitant valvular disease. Japanese Circ J 1982; 46: 433-441.
45. Goodman DJ, Rossen RM, Holloway EL, Alderman EL, Harrison DC. Effect of nitroprusside on felt ventricular dynamics in mitral regurgitation. Circulation 1974; 50: 1.025-1.032.
46. Weiland DS, Konstam MA, Salem DN, Martin TT, Cohen SR, Zile MR et al. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58: 1.046-1.050.
47. Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, Salvucci F et al. Dobuamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function and ventricular function. Am Heart J 1997; 134: 1.089-1.098.
48. Yoran C, Yellin EL, Gabbay S, Becker RM, Sonnenblick EH, Frater RWM. Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 1979; 43: 773.
49. Keren G, Laniado S, Sonnenblick EH, Lejemtel TH. Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a doppler echocardiographic study. Am Heart J 1989; 118: 748.
50. Beanlands RS, Bach DS, Raylman R, Armstrong WE, Wilson V, Montieth M. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol 1993; 22: 1.389-1.398.
51. Fenser MS, Feldman MD. Revisión de la insuficiencia mitral. Curr Probl Cardiol 1995; 4: 441-526.
52. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115: 381-388.
53. Batista RJV, Santos JLV, Cunha MA, Franzoni M, Araujo ACF, Takeshita N et al. Ventriculectomia parcial: um novo conceito no tratamiento cirúrgico de cardiopatias em fase final. Anais do XXII Congrasso Nacional de Cirurgia Cardíaea SBCC. 1995; 140-141.
54. Batista RJV, Santos JLV, Takeshita N, Bocchino L, Lima PN, Cunha MA. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 1996; 11: 96-97.
55. Bochi EA, Bellolti G, Moraes AV, Bacal F, Moreira LF, Esteves-Filho A et al. Clinical outcome after left ventricular surgical remodelling in patients with idiopathic dilated cardiomyopathy referred for heart transplantation. Short term results. Circulation 1997; 96 (Supl 2): 165-172.
56. McCarthy PM, Starling RC, Wong J, Scalia GM, Buda T, Vargo RL et al. Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 1997; 114: 755-765.
57. Batista RJV, Nery P, Bochino L, Takeshita N, Bhayana JN, Bergsland JN et al. Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 1997; 64: 634-638.
58. McCarthy JF, McCarthy PM, Starling RC, Smedira NG, Scalia GM, Wong J et al. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardio-Thorac Surg 1998; 13: 337-343.
59. Moreira LFP, Stolf NAG, Bocchi EA, Bacal F, Giorgi MCP, Parga JR et al. Partial left ventriculectomy with mitral valve preservation in the treatment of patients with dilated cardiomyopathy. J Thorac Cardiovasc Surg 1998; 115: 800-807.
60. Left ventricular reduction surgery (Society Position Paper). Ann Thorac Surg 1997; 63: 909-910.
61. Gorcsan III J, Feldman AM, Kormos RL, Mandarino WA, Demetris AJ, Batista RJV. Heterogenous immediate effects of partial left ventriculectomy on cardiac performance. Circulation 1998; 97: 839-842.
62. Popovic Z, Miric M, Sinis Neskovic AN, Jovovic L, Vuk L et al. Effects of partial left ventriculectomy on left ventricular performance in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 1998; 32: 1.801-1.808.